Middle East & Africa Coagulation Analyzers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Clinical Laboratory Analyzers and Point-of-care Testing Analyzers), Test (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimer Testing, Platelet Function Tests, Anti-Factor XA Tests, Heparin and Protamine Dose Response Tests for ACT, and Others), Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Other Technologies), and End Users (Hospitals, Clinical Laboratories, Point-of-Care Testing, and Others)
The Middle East & Africa coagulation analyzers market is expected to grow from US$ 193.71 million in 2022 to US$ 259.47 million by 2028. It is estimated to grow at a CAGR of 5.0% from 2022 to 2028.
Development of Point-of-Care (POC) Coagulation Analyzers is Driving the Middle East & Africa Coagulation Analyzers Market
A rapid, reliable assessment of hemostasis is essential for patients with trauma or other bleeding problems. Due to the requirements of sample preparation and the analytical process, routine coagulation assays cannot visualize the process of clot formation, and their results are obtained only after 30-90 minutes. Point-of-care (POC) devices such as viscoelastic coagulation tests, platelet function tests, blood gas analysis, and other coagulometers are available for assessment of hemostasis. A POC measurement tool can be used both inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzers provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians' offices, these devices can assist with patient management in pharmacies, care centers, and patients' homes. POC coagulation analyzers offer timely results without compromising diagnostic quality control provided by central labs. In POC testing, it is important to provide fast results, along with accuracy and quality assurance.
In 2021, Siemens Healthineers launched fully automated CN-3000 and CN-6000 systems, which are mid- and high-volume handheld POC coagulation testing devices. Siemens Healthineers' Xprecia Stride Coagulation Analyser was cleared by the FDA as a POC coagulation analyzers device. The device has demonstrated PT/INR (prothrombin time/international normalized ratio) testing performance equivalence to Roche CoaguChek XS.
Thus, the growing development of POC coagulation analyzer is likely to propel the Middle East & Africa coagulation analyzers market growth during the forecast period.
Middle East & Africa Coagulation Analyzers Market Overview
The Middle East & Africa consists of three major countries, namely the UAE, Saudi Arabia, and South Africa. The market is expected to have significant growth opportunities owing to the rising development in the medical facilities, increasing prevalence of blood disorders, and rise in incidences of atrial fibrillation and other cardiovascular diseases.
Saudi Arabia is among the well-established country in the Middle East region. It is accounted for as the richest economies and is developing in terms of the healthcare sector rapidly. However, the country is majorly dependent on imports for medical device products. The rising incidences of chronic and acute diseases such as cardiovascular disorders have led to increasing demand for coagulation analyzers in the country. Coronary heart disease constitutes one of the main health problems in Saudi Arabia, constituting the third most common cause of hospital-based mortality, second to accident and senility. According to Archives of Pharmacy Practice, the prevalence of coronary heart disease is at 6%, stipulating a high burden of disease and associated risk factors. Similarly, the increasing prevalence of cardiovascular diseases in the UAE will likely to increase the demand coagulation analyzers. According to a study conducted by Cleveland Clinic Abu Dhabi, more than half of the residents in UAE have been affected by heart disease during their lifespan. Cardiovascular disease is the prime cause of death in the UAE, with symptoms in patients often occurring a decade earlier than their counterparts in other developed nations. According to an article published by PLOS ONE, CVD contributes to 40% of all deaths. Its incidence is increasing in young adults mainly because of an increase in the burden of its known risk factors such as abdominal obesity (71.5%), dyslipidemia (74.0%), hypertension (43.0%), and diabetes (32.4%).
Also, rising prevalence of genetic blood disorder in the region is likely to increase the demand for coagulation analyzer in the market. The prevalence of genetic blood disorders (sickle cell anemia and thalassemia) varies among the different regions of the Kingdom of Saudi Arabia. The highest rates are recorded in the eastern and southern regions, while the rates are low in the central and northern regions of the Kingdom. Additionally, as per the Dubai Health Authority, in 2019, there were about 2,000 people with thalassaemia in the UAE. Further, the government-run Thalassaemia Centre in Dubai had around 850 patients and of which 450 were critical ones who needed regular blood transfusions. Additionally, as per the World Federation of Hemophilia, in South Africa, in 2019, ~24.6/100,000 males had hemophilia A and 5.0/100,000 males had hemophilia B. also, the prevalence of Von Willebrand Disease (VWD) with bleeding symptoms to primary care physicians appears to be approximately 1 in 1,000.
South Africa faces a chronic cardiovascular disease burden, including high rates of hypertension and cardiac arrest. South Africa is experiencing an increasing burden of cardiovascular diseases, including coronary heart disease (CHD) and stroke. According to WHO, it is estimated that the rate of premature death due to CVD amongst South African adults is projected to increase by 41% between 2000 and 2030. Moreover, in South Africa stroke is a leading cause of death and disability. An increase in the burden of stroke is expected as the population is experiencing a rapid epidemiological transition with increased exposure to and development of stroke risk factors, together with the aging of the population. Healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments and diagnoses.
Although the region remains highly exposed to political uncertainty, medical device exports will gain from accelerated economic growth in Sub-Saharan Africa, which will be aided by increased commodity prices and improved investor enthusiasm. In Sub-Saharan Africa, South Africa is the key business center for the medical device industry. A large percentage of medical device and lab equipment exports go to other African countries, with 12 African countries among the top 20 export destinations. Thus, owing to the factors mentioned above, the country is expected to provide an opportunistic scenario for coagulation analyzers market growth in South Africa.
In addition, development in technology, healthcare infrastructure has increased the use of online distribution channels for buying diagnostic devices. The other factors, such as increasing incidences of peripheral artery disease, and rising healthcare expenditure, are likely to lead to the growth of the market during the forecast period. In addition, the growing investment in the healthcare industry is expected to enhance market growth significantly.
Middle East & Africa Coagulation Analyzers Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Coagulation Analyzers Market Segmentation
The Middle East & Africa coagulation analyzers market is segmented into product, test, technology, end users, and country.
Based on product, the Middle East & Africa coagulation analyzers market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. The clinical laboratory analyzers segment held the larger Middle East & Africa coagulation analyzers market share in 2022.
Based on test, the Middle East & Africa coagulation analyzers market is segmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimer testing, platelet function tests, anti-factor xa tests, heparin and protamine dose response tests for act, and others. The prothrombin time testing segment held the largest Middle East & Africa coagulation analyzers market share in 2022.
Based on technology, the Middle East & Africa coagulation analyzers market is segmented into optical technology, mechanical technology, electrochemical technology, and other technologies . The optical technology segment held the largest Middle East & Africa coagulation analyzers market share in 2022.
Based on end users, the Middle East & Africa coagulation analyzers market is segmented into hospitals, clinical laboratories, point-of-care testing, and others . The clinical laboratories segment held the largest Middle East & Africa coagulation analyzers market share in 2022.
Based on country, the Middle East & Africa coagulation analyzers market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The Saudi Arabia dominated the Middle East & Africa coagulation analyzers market share in 2022.
Abbott Laboratories; Danaher Corp; F. Hoffmann-La Roche Ltd; Horiba Ltd.; Nihon Kohden Corp; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Sysmex Corporation; and Thermo Fisher Scientific Inc are the leading companies operating in the Middle East & Africa coagulation analyzers market.
Development of Point-of-Care (POC) Coagulation Analyzers is Driving the Middle East & Africa Coagulation Analyzers Market
A rapid, reliable assessment of hemostasis is essential for patients with trauma or other bleeding problems. Due to the requirements of sample preparation and the analytical process, routine coagulation assays cannot visualize the process of clot formation, and their results are obtained only after 30-90 minutes. Point-of-care (POC) devices such as viscoelastic coagulation tests, platelet function tests, blood gas analysis, and other coagulometers are available for assessment of hemostasis. A POC measurement tool can be used both inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzers provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians' offices, these devices can assist with patient management in pharmacies, care centers, and patients' homes. POC coagulation analyzers offer timely results without compromising diagnostic quality control provided by central labs. In POC testing, it is important to provide fast results, along with accuracy and quality assurance.
In 2021, Siemens Healthineers launched fully automated CN-3000 and CN-6000 systems, which are mid- and high-volume handheld POC coagulation testing devices. Siemens Healthineers' Xprecia Stride Coagulation Analyser was cleared by the FDA as a POC coagulation analyzers device. The device has demonstrated PT/INR (prothrombin time/international normalized ratio) testing performance equivalence to Roche CoaguChek XS.
Thus, the growing development of POC coagulation analyzer is likely to propel the Middle East & Africa coagulation analyzers market growth during the forecast period.
Middle East & Africa Coagulation Analyzers Market Overview
The Middle East & Africa consists of three major countries, namely the UAE, Saudi Arabia, and South Africa. The market is expected to have significant growth opportunities owing to the rising development in the medical facilities, increasing prevalence of blood disorders, and rise in incidences of atrial fibrillation and other cardiovascular diseases.
Saudi Arabia is among the well-established country in the Middle East region. It is accounted for as the richest economies and is developing in terms of the healthcare sector rapidly. However, the country is majorly dependent on imports for medical device products. The rising incidences of chronic and acute diseases such as cardiovascular disorders have led to increasing demand for coagulation analyzers in the country. Coronary heart disease constitutes one of the main health problems in Saudi Arabia, constituting the third most common cause of hospital-based mortality, second to accident and senility. According to Archives of Pharmacy Practice, the prevalence of coronary heart disease is at 6%, stipulating a high burden of disease and associated risk factors. Similarly, the increasing prevalence of cardiovascular diseases in the UAE will likely to increase the demand coagulation analyzers. According to a study conducted by Cleveland Clinic Abu Dhabi, more than half of the residents in UAE have been affected by heart disease during their lifespan. Cardiovascular disease is the prime cause of death in the UAE, with symptoms in patients often occurring a decade earlier than their counterparts in other developed nations. According to an article published by PLOS ONE, CVD contributes to 40% of all deaths. Its incidence is increasing in young adults mainly because of an increase in the burden of its known risk factors such as abdominal obesity (71.5%), dyslipidemia (74.0%), hypertension (43.0%), and diabetes (32.4%).
Also, rising prevalence of genetic blood disorder in the region is likely to increase the demand for coagulation analyzer in the market. The prevalence of genetic blood disorders (sickle cell anemia and thalassemia) varies among the different regions of the Kingdom of Saudi Arabia. The highest rates are recorded in the eastern and southern regions, while the rates are low in the central and northern regions of the Kingdom. Additionally, as per the Dubai Health Authority, in 2019, there were about 2,000 people with thalassaemia in the UAE. Further, the government-run Thalassaemia Centre in Dubai had around 850 patients and of which 450 were critical ones who needed regular blood transfusions. Additionally, as per the World Federation of Hemophilia, in South Africa, in 2019, ~24.6/100,000 males had hemophilia A and 5.0/100,000 males had hemophilia B. also, the prevalence of Von Willebrand Disease (VWD) with bleeding symptoms to primary care physicians appears to be approximately 1 in 1,000.
South Africa faces a chronic cardiovascular disease burden, including high rates of hypertension and cardiac arrest. South Africa is experiencing an increasing burden of cardiovascular diseases, including coronary heart disease (CHD) and stroke. According to WHO, it is estimated that the rate of premature death due to CVD amongst South African adults is projected to increase by 41% between 2000 and 2030. Moreover, in South Africa stroke is a leading cause of death and disability. An increase in the burden of stroke is expected as the population is experiencing a rapid epidemiological transition with increased exposure to and development of stroke risk factors, together with the aging of the population. Healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments and diagnoses.
Although the region remains highly exposed to political uncertainty, medical device exports will gain from accelerated economic growth in Sub-Saharan Africa, which will be aided by increased commodity prices and improved investor enthusiasm. In Sub-Saharan Africa, South Africa is the key business center for the medical device industry. A large percentage of medical device and lab equipment exports go to other African countries, with 12 African countries among the top 20 export destinations. Thus, owing to the factors mentioned above, the country is expected to provide an opportunistic scenario for coagulation analyzers market growth in South Africa.
In addition, development in technology, healthcare infrastructure has increased the use of online distribution channels for buying diagnostic devices. The other factors, such as increasing incidences of peripheral artery disease, and rising healthcare expenditure, are likely to lead to the growth of the market during the forecast period. In addition, the growing investment in the healthcare industry is expected to enhance market growth significantly.
Middle East & Africa Coagulation Analyzers Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Coagulation Analyzers Market Segmentation
The Middle East & Africa coagulation analyzers market is segmented into product, test, technology, end users, and country.
Based on product, the Middle East & Africa coagulation analyzers market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. The clinical laboratory analyzers segment held the larger Middle East & Africa coagulation analyzers market share in 2022.
Based on test, the Middle East & Africa coagulation analyzers market is segmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimer testing, platelet function tests, anti-factor xa tests, heparin and protamine dose response tests for act, and others. The prothrombin time testing segment held the largest Middle East & Africa coagulation analyzers market share in 2022.
Based on technology, the Middle East & Africa coagulation analyzers market is segmented into optical technology, mechanical technology, electrochemical technology, and other technologies . The optical technology segment held the largest Middle East & Africa coagulation analyzers market share in 2022.
Based on end users, the Middle East & Africa coagulation analyzers market is segmented into hospitals, clinical laboratories, point-of-care testing, and others . The clinical laboratories segment held the largest Middle East & Africa coagulation analyzers market share in 2022.
Based on country, the Middle East & Africa coagulation analyzers market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The Saudi Arabia dominated the Middle East & Africa coagulation analyzers market share in 2022.
Abbott Laboratories; Danaher Corp; F. Hoffmann-La Roche Ltd; Horiba Ltd.; Nihon Kohden Corp; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Sysmex Corporation; and Thermo Fisher Scientific Inc are the leading companies operating in the Middle East & Africa coagulation analyzers market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Coagulation Analyzer Market – By Product
1.3.2 Middle East & Africa Coagulation Analyzer Market – By Test
1.3.3 Middle East & Africa Coagulation Analyzer Market – By Technology
1.3.4 Middle East & Africa Coagulation Analyzer Market – By End Users
1.3.5 Middle East & Africa Coagulation Analyzer Market – By Country
2. MIDDLE EAST & AFRICA COAGULATION ANALYZER MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA COAGULATION ANALYZER MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Middle East and Africa – PEST Analysis
4.3 Expert Opinion
5. MIDDLE EAST & AFRICA COAGULATION ANALYZER MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Prevalence of Blood Disorders
5.1.2 Rising Incidence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 High Costs and Stringent Regulations Associated with Coagulation Analyzers
5.3 Market Opportunities
5.3.1 Increasing Organic and Inorganic Strategies by Key Players
5.4 Future Trends
5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis
6. COAGULATION ANALYZER MARKET – MIDDLE EAST & AFRICA ANALYSIS
6.1 Middle East & Africa Coagulation Analyzer Market Revenue Forecast & Analysis
7. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY PRODUCT TYPE
7.1 Overview
7.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by Product Type (2021 and 2028)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 System
7.3.3.1 Overview
7.3.3.2 System: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Consumables
7.3.4.1 Overview
7.3.5 Consumables: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Point of Care Testing Analyzers
7.4.1 Overview
7.4.2 Point of Care Testing Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY TEST
8.1 Overview
8.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by Test (2021 and 2028)
8.3 Prothrombin Time Testing
8.3.1 Overview
8.3.2 Prothrombin Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Fibrinogen Testing
8.4.1 Overview
8.4.2 Fibrinogen Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Activated Clotting Time Testing
8.5.1 Overview
8.5.2 Activated Clotting Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.6 D-Dimer Testing
8.6.1 Overview
8.6.2 D-Dimer Testing : Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Activated Partial Thromboplastin Time Testing
8.7.1 Overview
8.7.2 Activated Partial Thromboplastin Time Testing: Middle East & Africa Coagulation Analyzers Market –Revenue and Forecast to 2028 (US$ Million)
8.8 Platelets Function Testing
8.8.1 Overview
8.8.2 Platelets Function Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY TECHNOLOGY
9.1 Overview
9.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by Technology (2021 and 2028)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.1.1 Mechanical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Electrochemical Technology
9.5.1.1 Overview
9.5.2 Electrochemical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY END USER
10.1 Overview
10.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by End User (2021 and 2028)
10.2.1 Clinical Laboratories
10.2.1.1 Overview
10.2.1.2 Clinical Laboratories: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.2.2 Hospital
10.2.2.1 Overview
10.2.2.2 Hospital: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Others
10.2.3.1 Overview
10.2.3.2 Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
11. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS AND FORECASTS TO 2028 – COUNTRY ANALYSIS
11.1 Overview
11.1.1 Middle East & Africa Coagulation Analyzers Market, by Country, 2021& 2028 (%)
11.1.1.1 Saudi Arabia: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Saudi Arabia: Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.1.1.1 Saudi Arabia: Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.1.2 Saudi Arabia Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.3 Saudi Arabia Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.4 Saudi Arabia Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
11.1.1.2 UAE: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 UAE: Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.2.1.1 UAE: Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.2.2 UAE Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.3 UAE Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.4 UAE Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
11.1.1.3 South Africa: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 South Africa: Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.3.1.1 South Africa: Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.3.2 South Africa Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.3 South Africa Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.4 South Africa Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
11.1.1.4 Rest of Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Rest of Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.4.1.1 Rest of Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.4.2 Rest of Middle East & Africa Coagulation Analyzers Market, by Test, 2019–2028 (USD Million)
11.1.1.4.3 Rest of Middle East & Africa Coagulation Analyzers Market, by Technology, 2019–2028 (USD Million)
11.1.1.4.4 Rest of Middle East & Africa Coagulation Analyzers Market, by End User, 2019–2028 (USD Million)
12. COAGULATION ANALYZERS MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Coagulation Analyzers Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Siemens Healthcare GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Horiba Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nihon Kohden Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Coagulation Analyzer Market – By Product
1.3.2 Middle East & Africa Coagulation Analyzer Market – By Test
1.3.3 Middle East & Africa Coagulation Analyzer Market – By Technology
1.3.4 Middle East & Africa Coagulation Analyzer Market – By End Users
1.3.5 Middle East & Africa Coagulation Analyzer Market – By Country
2. MIDDLE EAST & AFRICA COAGULATION ANALYZER MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA COAGULATION ANALYZER MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Middle East and Africa – PEST Analysis
4.3 Expert Opinion
5. MIDDLE EAST & AFRICA COAGULATION ANALYZER MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Prevalence of Blood Disorders
5.1.2 Rising Incidence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 High Costs and Stringent Regulations Associated with Coagulation Analyzers
5.3 Market Opportunities
5.3.1 Increasing Organic and Inorganic Strategies by Key Players
5.4 Future Trends
5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis
6. COAGULATION ANALYZER MARKET – MIDDLE EAST & AFRICA ANALYSIS
6.1 Middle East & Africa Coagulation Analyzer Market Revenue Forecast & Analysis
7. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY PRODUCT TYPE
7.1 Overview
7.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by Product Type (2021 and 2028)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 System
7.3.3.1 Overview
7.3.3.2 System: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Consumables
7.3.4.1 Overview
7.3.5 Consumables: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Point of Care Testing Analyzers
7.4.1 Overview
7.4.2 Point of Care Testing Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY TEST
8.1 Overview
8.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by Test (2021 and 2028)
8.3 Prothrombin Time Testing
8.3.1 Overview
8.3.2 Prothrombin Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Fibrinogen Testing
8.4.1 Overview
8.4.2 Fibrinogen Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Activated Clotting Time Testing
8.5.1 Overview
8.5.2 Activated Clotting Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.6 D-Dimer Testing
8.6.1 Overview
8.6.2 D-Dimer Testing : Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Activated Partial Thromboplastin Time Testing
8.7.1 Overview
8.7.2 Activated Partial Thromboplastin Time Testing: Middle East & Africa Coagulation Analyzers Market –Revenue and Forecast to 2028 (US$ Million)
8.8 Platelets Function Testing
8.8.1 Overview
8.8.2 Platelets Function Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY TECHNOLOGY
9.1 Overview
9.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by Technology (2021 and 2028)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.1.1 Mechanical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Electrochemical Technology
9.5.1.1 Overview
9.5.2 Electrochemical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS – BY END USER
10.1 Overview
10.2 Middle East & Africa Coagulation Analyzers Market Revenue Share, by End User (2021 and 2028)
10.2.1 Clinical Laboratories
10.2.1.1 Overview
10.2.1.2 Clinical Laboratories: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.2.2 Hospital
10.2.2.1 Overview
10.2.2.2 Hospital: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Others
10.2.3.1 Overview
10.2.3.2 Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
11. MIDDLE EAST & AFRICA COAGULATION ANALYZERS MARKET ANALYSIS AND FORECASTS TO 2028 – COUNTRY ANALYSIS
11.1 Overview
11.1.1 Middle East & Africa Coagulation Analyzers Market, by Country, 2021& 2028 (%)
11.1.1.1 Saudi Arabia: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Saudi Arabia: Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.1.1.1 Saudi Arabia: Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.1.2 Saudi Arabia Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.3 Saudi Arabia Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.4 Saudi Arabia Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
11.1.1.2 UAE: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 UAE: Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.2.1.1 UAE: Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.2.2 UAE Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.3 UAE Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.4 UAE Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
11.1.1.3 South Africa: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 South Africa: Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.3.1.1 South Africa: Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.3.2 South Africa Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.3 South Africa Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.4 South Africa Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
11.1.1.4 Rest of Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Rest of Middle East & Africa Coagulation Analyzers Market, by Product, 2019–2028 (USD Million)
11.1.1.4.1.1 Rest of Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers, 2019–2028 (USD Million)
11.1.1.4.2 Rest of Middle East & Africa Coagulation Analyzers Market, by Test, 2019–2028 (USD Million)
11.1.1.4.3 Rest of Middle East & Africa Coagulation Analyzers Market, by Technology, 2019–2028 (USD Million)
11.1.1.4.4 Rest of Middle East & Africa Coagulation Analyzers Market, by End User, 2019–2028 (USD Million)
12. COAGULATION ANALYZERS MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Coagulation Analyzers Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Siemens Healthcare GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Horiba Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nihon Kohden Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Coagulation Analyzers Market, by Clinical Laboratory Analyzers– Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Coagulation Analyzers Market, by Clinical Laboratory Analyzers – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East & Africa Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Coagulation Analyzers Market, by Test– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East & Africa Coagulation Analyzers Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Coagulation Analyzers Market
Table 22. Recent Organic Growth Strategies in the Coagulation Analyzers Market
Table 23. Glossary of Terms, Coagulation Analyzers Market
Table 1. Saudi Arabia Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Coagulation Analyzers Market, by Clinical Laboratory Analyzers– Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Coagulation Analyzers Market, by Clinical Laboratory Analyzers – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Coagulation Analyzers Market, by Test – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Coagulation Analyzers Market, by End Users – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East & Africa Coagulation Analyzers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East & Africa Coagulation Analyzers Market, by Clinical Laboratory Analyzers – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Coagulation Analyzers Market, by Test– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Coagulation Analyzers Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East & Africa Coagulation Analyzers Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Coagulation Analyzers Market
Table 22. Recent Organic Growth Strategies in the Coagulation Analyzers Market
Table 23. Glossary of Terms, Coagulation Analyzers Market
LIST OF FIGURES
Figure 1. Middle East & Africa Coagulation Analyzer Market Segmentation
Figure 2. Middle East & Africa Coagulation Analyzer Market Segmentation, By Country
Figure 3. Middle East & Africa Coagulation Analyzer Market Overview
Figure 4. Clinical Laboratory Analyzers Held Largest Share of Type Segment in Middle East & Africa Coagulation Analyzer Market
Figure 5. The UAE Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East and Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Coagulation Analyzer Market Impact Analysis of Driver and Restraints
Figure 9. Middle East & Africa Coagulation Analyzer Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Middle East & Africa Coagulation Analyzers Market Revenue Share, by Product Type (2021 and 2028)
Figure 11. Clinical Laboratory Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. System: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Point of Care Testing Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Middle East & Africa Coagulation Analyzers Market Revenue Share, by Test (2021 and 2028)
Figure 16. Prothrombin Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Fibrinogen Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Activated Clotting Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. D-Dimer Testing : Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Activated Partial Thromboplastin Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Platelets Function Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa Coagulation Analyzers Market Revenue Share, by Technology (2021 and 2028)
Figure 24. Optical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Mechanical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Electrochemical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Middle East & Africa Coagulation Analyzers Market Revenue Share, by End User (2021 and 2028)
Figure 29. Clinical Laboratories: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Hospital: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Middle East & Africa Coagulation Analyzers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Middle East & Africa Coagulation Analyzers Market, by Country, 2021& 2028 (%)
Figure 34. Saudi Arabia: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. UAE: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. South Africa: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Rest of Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Growth Strategies in the Coagulation Analyzers Market
Figure 1. Middle East & Africa Coagulation Analyzer Market Segmentation
Figure 2. Middle East & Africa Coagulation Analyzer Market Segmentation, By Country
Figure 3. Middle East & Africa Coagulation Analyzer Market Overview
Figure 4. Clinical Laboratory Analyzers Held Largest Share of Type Segment in Middle East & Africa Coagulation Analyzer Market
Figure 5. The UAE Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East and Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Coagulation Analyzer Market Impact Analysis of Driver and Restraints
Figure 9. Middle East & Africa Coagulation Analyzer Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Middle East & Africa Coagulation Analyzers Market Revenue Share, by Product Type (2021 and 2028)
Figure 11. Clinical Laboratory Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. System: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Point of Care Testing Analyzers: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Middle East & Africa Coagulation Analyzers Market Revenue Share, by Test (2021 and 2028)
Figure 16. Prothrombin Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Fibrinogen Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Activated Clotting Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. D-Dimer Testing : Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Activated Partial Thromboplastin Time Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Platelets Function Testing: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa Coagulation Analyzers Market Revenue Share, by Technology (2021 and 2028)
Figure 24. Optical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Mechanical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Electrochemical Technology: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Middle East & Africa Coagulation Analyzers Market Revenue Share, by End User (2021 and 2028)
Figure 29. Clinical Laboratories: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Hospital: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Middle East & Africa Coagulation Analyzers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Middle East & Africa Coagulation Analyzers Market, by Country, 2021& 2028 (%)
Figure 34. Saudi Arabia: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. UAE: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. South Africa: Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Rest of Middle East & Africa Coagulation Analyzers Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Growth Strategies in the Coagulation Analyzers Market
